Zentalis Pharmaceuticals, Inc. - COM (ZNTL)

Historical Portfolio Holders from Q2 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
84 M
Holdings value Q1 2024
$1.32 B
Value change Q1 2024
+$58.2 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
129
Number of buys Q1 2024
71
Number of sells Q1 2024
-48
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
98943L107
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 84 M $1.32 B +$58.2 M $15.76 129
2023 Q4 80.4 M $1.22 B -$20.4 M $15.15 116
2023 Q3 80 M $1.61 B -$51.6 M $20.06 133
2023 Q2 82.1 M $2.31 B +$442 M $28.21 129
2023 Q1 67 M $1.15 B +$45.9 M $17.20 107
2022 Q4 64.3 M $1.3 B +$105 M $20.14 101
2022 Q3 55.2 M $1.2 B -$49.4 M $21.66 107
2022 Q2 58.1 M $1.63 B +$360 M $28.10 111
2022 Q1 44.3 M $2.04 B +$46.9 M $46.14 121
2021 Q4 42.8 M $3.6 B +$96.2 M $84.06 131
2021 Q3 41.2 M $2.75 B +$112 M $66.64 111
2021 Q2 39.4 M $2.1 B +$205 M $53.20 118
2021 Q1 36.3 M $1.58 B -$55.2 M $43.39 92
2020 Q4 36.9 M $1.92 B +$310 M $51.94 101
2020 Q3 31.6 M $1.03 B +$170 M $32.69 65
2020 Q2 26.9 M $1.28 B +$1.28 B $48.02 61